1887
Preview this article:
Zoom in
Zoomout

Chlamydial vaccine development, Page 1 of 1

| /docserver/preview/fulltext/jmm/52/7/JMM5207.537-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.05093-0
2003-07-01
2020-10-26
Loading full text...

Full text loading...

/deliver/fulltext/jmm/52/7/JM520701.html?itemId=/content/journal/jmm/10.1099/jmm.0.05093-0&mimeType=html&fmt=ahah

References

  1. Antex Biologics 2003; Antex files Chlamydia investigational new drug application with FDA. STD vaccine clinical trial Press release, 3 February 2003 http://www.antexbiologics.com/news_pr/pr030203.phtm
  2. Buzoni-Gatel D, Guilloteau L, Bernard F, Bernard S, Chardes T, Rocca A. 1992; Protection against Chlamydia psittaci in mice conferred by Lyt-2+ T cells. Immunology 77:284–288
    [Google Scholar]
  3. de la Maza M. A, de la Maza L. M. 1995; A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. Vaccine 13:119–127 [CrossRef]
    [Google Scholar]
  4. Entrican G, Buxton D, Longbottom D. 2001; Chlamydial infection in sheep: immune control versus fetal pathology. J R Soc Med 94:273–277
    [Google Scholar]
  5. Fling S. P, Sutherland R. A, Steele L. N, Hess B, D'Orazio S. E. F, Maisonneuve J, Lampe M. F, Probst P, Starnbach M. N. 2001; CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis . Proc Natl Acad Sci U S A 98:1160–1165 [CrossRef]
    [Google Scholar]
  6. Gentschev I, Dietrich G, Spreng S, Pilgrim S, Stritzker J, Kolb-Maurer A, Goebel W. 2002; Delivery of protein antigens and DNA by attenuated intracellular bacteria. Int J Med Microbiol 291:577–582
    [Google Scholar]
  7. Hayes L. J, Conlan J. W, Everson J. S, Ward M. E, Clarke I. N. 1991; Chlamydia trachomatis major outer membrane protein epitopes expressed as fusions with LamB in an attenuated aroA strain of Salmonella typhimurium ; their application as potential immunogens. J Gen Microbiol 137:1557–1564 [CrossRef]
    [Google Scholar]
  8. Henderson I. R, Lam A. C. 2001; Polymorphic proteins of Chlamydia spp.–autotransporters beyond the Proteobacteria. Trends Microbiol 9:573–578 [CrossRef]
    [Google Scholar]
  9. Herring A. J, Jones G. E, Dunbar S. M, Nettleton P. F, Fitzgerald T. A, Anderson I. E, Chapman S. N, Wilson T. M. A. 1998; Recombinant vaccines against Chlamydia psittaci –an overview of results using bacterial expression and a new approach using a plant virus ‘overcoat’ system. In Proceedings of the Ninth International Symposium on Human Chlamydial Infection pp 434–437 Edited by Stephens R. S., Byrne G. I. , Christiansen G. 7 others San Francisco: International Chlamydia Symposium;
    [Google Scholar]
  10. Hsia R. C, Pannekoek Y, Ingerowski E, Bavoil P. M. 1997; Type III secretion genes identify a putative virulence locus of Chlamydia . Mol Microbiol 25:351–359 [CrossRef]
    [Google Scholar]
  11. Igietseme J. U. 2002; Functional immunobiology of Chlamydia : vaccine perspective. In Proceedings of the Tenth International Symposium on Human Chlamydial Infections pp 223–232 Edited by Schachter J., Christiansen G., Clarke I. N. 11 others San Francisco: International Chlamydia Symposium;
    [Google Scholar]
  12. Lampe M. F, Ballweber L. M, Stamm W. E. 1998a; Cloning and sequence analysis of a putative cytolysin from Chlamydia trachomatis . In Proceedings of the Ninth International Symposium on Human Chlamydial Infection pp 555–558 Edited by Stephens R. S., Byrne G., Christiansen I. G. 7 others San Francisco: International Chlamydia Symposium;
    [Google Scholar]
  13. Lampe M. F, Wilson C. B, Bevan M. J, Starnbach M. N. 1998b; Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect Immun 66:5457–5461
    [Google Scholar]
  14. Longbottom D, Coulter L. J. 2003; Animal chlamydioses and zoonotic implications. J Comp Pathol 128:217–244 [CrossRef]
    [Google Scholar]
  15. Longbottom D, Findlay J, Vretou E, Dunbar S. M. 1998a; Immunoelectron microscopic localisation of the OMP90 family on the outer membrane surface of Chlamydia psittaci . FEMS Microbiol Lett 164:111–117 [CrossRef]
    [Google Scholar]
  16. Longbottom D, Russell M, Dunbar S. M, Jones G. E, Herring A. J. 1998b; Molecular cloning and characterization of the genes coding for the highly immunogenic cluster of 90-kilodalton envelope proteins from the Chlamydia psittaci subtype that causes abortion in sheep. Infect Immun 66:1317–1324
    [Google Scholar]
  17. Lu H, Zhong G. M. 1999; Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection. Infect Immun 67:1763–1769
    [Google Scholar]
  18. Moore T, Ananaba G. A, Bolier J, Bowers S, Belay T, Eko F. O, Igietseme J. U. 2002; Fc receptor regulation of protective immunity against Chlamydia trachomatis . Immunology 105:213–221 [CrossRef]
    [Google Scholar]
  19. Murdin A. D, Su H, Manning D. S, Klein M. H, Parnell M. J, Caldwell H. D. 1993; A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic. Infect Immun 61:4406–4414
    [Google Scholar]
  20. Murdin A. D, Dunn P, Sodoyer R, Wang J, Caterini J, Brunham R. C, Aujame L, Oomen R. 2000; Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection. J Infect Dis 181:Suppl. 3S544–S551 [CrossRef]
    [Google Scholar]
  21. Pal S, Barnhart K. M, Wei Q, Abai A. M, Peterson E. M, de la Maza L. M. 1999; Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge. Vaccine 17:459–465 [CrossRef]
    [Google Scholar]
  22. Rank R. G. 1999; Models of immunity. In Chlamydia: Intracellular BiologyPathogenesis and Immunity pp 239–295 Edited by Stephens R. S. Washington, DC: American Society for Microbiology;
    [Google Scholar]
  23. Rank R. G, Batteiger B. E. 1989; Protective role of serum antibody in immunity to chlamydial genital infection. Infect Immun 57:299–301
    [Google Scholar]
  24. Rank R. G, White H. J, Barron A. L. 1979; Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun 26:573–579
    [Google Scholar]
  25. Read T. D, Brunham R. C, Shen C. 22 other authors 2000; Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 28:1397–1406 [CrossRef]
    [Google Scholar]
  26. Rockey D. D, Lenart J, Stephens R. S. 2000; Genome sequencing and our understanding of chlamydiae. Infect Immun 68:5473–5479 [CrossRef]
    [Google Scholar]
  27. Saikku P. 1998; Chlamydia pneumoniae –clinical spectrum. In Proceedings of the Ninth International Symposium on Human Chlamydial Infection pp 145–154 Edited by Stephens R. S., Byrne G. I., Christiansen G. , 7 others. San Francisco: International Chlamydia Symposium;
    [Google Scholar]
  28. Schachter J. 1988; Overview of human diseases. In Microbiology of Chlamydia pp 153–165 Edited by Barron A. L. Boca Raton, FL: CRC Press;
    [Google Scholar]
  29. Shaw J, Grund V, Durling L, Crane D, Caldwell H. D. 2002; Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4+ type 2 rather than type 1 immune response that is not protective. Infect Immun 70:1097–1105 [CrossRef]
    [Google Scholar]
  30. Stagg A. J. 1998; Vaccines against Chlamydia : approaches and progress. Mol Med Today 4:166–173 [CrossRef]
    [Google Scholar]
  31. Stephens R. S, Kalman S, Lammel C. 9 other authors 1998; Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis . Science 282:754–759 [CrossRef]
    [Google Scholar]
  32. Storz J. 1988; Overview of animal diseases induced by chlamydial infections. In Microbiology of Chlamydia pp 167–192 Edited by Barron A. L. Boca Raton, FL: CRC Press;
    [Google Scholar]
  33. Stuart E. S, Tirrell S. M, MacDonald A. B. 1987; Characterization of an antigen secreted by Chlamydia -infected cell culture. Immunology 61:527–533
    [Google Scholar]
  34. Su H, Feilzer K, Caldwell H. D, Morrison R. P. 1997; Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect Immun 65:1993–1999
    [Google Scholar]
  35. Su H, Messer R, Whitmire W, Fischer E, Portis J. C, Caldwell H. D. 1998; Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae. J Exp Med 188:809–818 [CrossRef]
    [Google Scholar]
  36. Turner M. S, Giffard P. M. 1999; Expression of Chlamydia psittaci - and human immunodeficiency virus-derived antigens on the cell surface of Lactobacillus fermentum BR11 as fusions to BspA. Infect Immun 67:5486–5489
    [Google Scholar]
  37. Vanrompay D, Cox E, Vandenbussche F, Volckaert G, Goddeeris B. 1999; Protection of turkeys against Chlamydia psittaci challenge by gene gun-based DNA immunizations. Vaccine 17:2628–2635 [CrossRef]
    [Google Scholar]
  38. Ward M. E. 1999; Mechanisms of disease. In Chlamydia: Intracellular BiologyPathogenesis and Immunity pp 171–210 Edited by Stephens R. S. Washington, DC: American Society for Microbiology;
    [Google Scholar]
  39. Zhang D, Yang X, Berry J, Shen C, McClarty G, Brunham R. C. 1997; DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection. J Infect Dis 176:1035–1040 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.05093-0
Loading

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error